Translational Andrology and Urology JCR impact factor overview
Automatically generated from the journal record shown on this page.
Clarivate JCR impact factor overview
Translational Andrology and Urology is listed in this directory with bibliometric information for 2025. It is published by AME PUBLISHING COMPANY. The database records a Journal Impact Factor of 1.700, presented as a Clarivate Journal Citation Reports (JCR)-based metric. Its listed JCR Impact Factor quartile is Q3.
Ranking and quartile
The recorded JCR Impact Factor category rank is 79 out of 133 journals in its listed category. A Q3 designation describes the journal’s position within its subject category; it should not be used as a direct measure of the quality of an individual article.
Citation profile
The record contains 4,561 total citations, 188 total articles, 234 citable items. The five-year Impact Factor is 2.300, which is 0.600 points above the listed standard Journal Impact Factor. These values use different citation windows and should be interpreted together rather than as a direct trend. The Journal Impact Factor without journal self-citations is recorded as 1.600. The Journal Citation Indicator is listed as 0.650.
Citation half-life
The cited half-life is recorded as 4.9 years, describing the median age of articles cited in the reporting year. The citing half-life is 5.7 years, reflecting the median age of references used by the journal’s articles.
Journal identifiers and verification
Translational Andrology and Urology is identified in this record by print ISSN 2223-4683 and electronic ISSN 2223-4691. Use the ISSN when checking library catalogues, publisher records, indexing databases, or the official Clarivate Journal Citation Reports entry.
Complete journal information
All values below come directly from the database record.
| Journal name | Translational Andrology and Urology |
|---|---|
| Abbreviated journal | TRANSL ANDROL UROL |
| Publisher | AME PUBLISHING COMPANY |
| Metric year | 2025 |
| Overall rank | 9,720 |
| ISSN | 2223-4683 |
| eISSN | 2223-4691 |
| Total cites | 4,561 |
| Total articles | 188 |
| Citable items | 234 |
| Cited half-life | 4.9 years |
| Citing half-life | 5.7 years |
| JCR-based Journal Impact Factor | 1.700 |
| 5-Year Impact Factor | 2.300 |
| Impact Factor without journal self-cites | 1.600 |
| Journal Citation Indicator | 0.650 |
| JCR Impact Factor quartile | Q3 |
| JCR category rank | 79/133 |
| Database record updated |
Frequently asked questions
What is the 2025 JCR-based Journal Impact Factor of Translational Andrology and Urology?
The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Translational Andrology and Urology is 1.700 for the 2025 metric year.
What quartile is Translational Andrology and Urology?
Translational Andrology and Urology is listed in quartile Q3. Quartiles describe a journal’s position within a subject category and should be interpreted within that field.
Who publishes Translational Andrology and Urology?
Translational Andrology and Urology is listed as being published by AME PUBLISHING COMPANY.
Can a JCR Journal Impact Factor be used to judge an individual article?
No. The Journal Impact Factor is a journal-level citation measure reported in Clarivate Journal Citation Reports. It does not measure the quality, reliability or influence of every individual article published by that journal.
Related journal profiles
Additional records from the same publisher or with a similar listed JCR Impact Factor.